Immucell ICCC
NASDAQ ICCC
$10.45 -0.06 (-0.57%)
As of: Oct 20, 2026 · 3:59 PM EDT

Immucell (ICCC) EPS (Basic) (2010 - 2026)

Updated

Immucell (ICCC) recorded EPS (Basic) of $0.20 in Q2 2026, up 264.2% from $0.06 a year earlier.

Analysis

Immucell (ICCC) EPS (Basic) (2010 - 2026) Analysis & Trends

On a TTM basis, Immucell's EPS (Basic) came in at -$0.07 as of Jun 30, 2026; for FY2025, it came in at -$0.12.

  • Across earlier years, EPS (Basic) came in at -$0.26 in FY2024, -$0.75 in FY2023, -$0.32 in FY2022 and -$0.01 in FY2021.
  • The Q2 2026 figure is the highest quarterly EPS (Basic) in data going back to Q2 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.95
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 2.30
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.04
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -0.54
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.68
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.62
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.40
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -8.44
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -0.04
10 Immucell 94.41 Mn 71.86 Mn 2.44 Mn 0.20
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.20
Dec 31, 2025 -0.32
Sep 30, 2025 -0.02
Jun 30, 2025 0.06
Mar 31, 2025 0.16
Dec 31, 2024 0.06
Sep 30, 2024 -0.09
Jun 30, 2024 -0.20
Mar 31, 2024 -0.06
Dec 31, 2023 -0.15
Sep 30, 2023 -0.12
Jun 30, 2023 -0.18
Mar 31, 2023 -0.30
Dec 31, 2022 -0.22
Sep 30, 2022 -0.08
Jun 30, 2022 -0.18
Mar 31, 2022 0.13
Dec 31, 2021 0.01
Sep 30, 2021 0.02
Jun 30, 2021 0.02
API Access

Immucell EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=ICCC&period=max&api_key=YOUR_API_KEY